Latest filings (excl ownership)
15-12G
Securities registration termination
26 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
S-8 POS
Registration of securities for employees (post-effective amendment)
25 Feb 20
8-K
Submission of Matters to a Vote of Security Holders
14 Feb 20
8-K
Completion of Acquisition or Disposition of Assets
14 Feb 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
425
Business combination disclosure
3 Oct 19
425
Business combination disclosure
23 Sep 19
8-K
Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals
18 Sep 19
425
Business combination disclosure
18 Sep 19
425
Business combination disclosure
13 Sep 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
8-K
Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter
13 Aug 19
8-K
Departure of Directors or Certain Officers
24 Jul 19
8-K
Other Events
22 Jul 19
8-K
Other Events
19 Jun 19
8-K
Other Events
10 Jun 19
S-8
Registration of securities for employees
10 Jun 19
8-K
Regulation FD Disclosure
31 May 19
8-K
Submission of Matters to a Vote of Security Holders
30 May 19
8-K
Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 million, a 18.0% Increase From Comparable Quarter in the Prior Year
15 May 19
10-Q
2019 Q1
Quarterly report
15 May 19
S-8
Registration of securities for employees
30 Apr 19
DEF 14A
Definitive proxy
30 Apr 19
8-K
Other Events
19 Apr 19
8-K
Regulation FD Disclosure
11 Apr 19
8-K
Revenue growth of 2.7x compared to Fiscal 2017 Revenues
1 Apr 19
10-K
2018 FY
Annual report
1 Apr 19
8-K
Amendments to Articles of Incorporation or Bylaws
15 Mar 19
8-K
Submission of Matters to a Vote of Security Holders
26 Feb 19
424B3
Prospectus supplement
13 Feb 19
EFFECT
Notice of effectiveness
12 Feb 19
S-1/A
IPO registration (amended)
8 Feb 19
DEF 14A
Definitive proxy
17 Jan 19
S-1
IPO registration
14 Jan 19
Latest ownership filings
SC 13D/A
Beneficial ownership report (amended)
20 Feb 20
4
Steven Boyd
19 Feb 20
4
Steven Boyd
19 Feb 20
SC 13G
Innovus Pharmaceuticals, Inc.
15 Jan 20
4
VIVIAN H LIU
7 Jan 20
4
Dean Nuhaily
7 Jan 20
4
ZIAD MIRZA
7 Jan 20
4
VIVIAN H LIU
2 Oct 19
4
ZIAD MIRZA
2 Oct 19
4
Dean Nuhaily
2 Oct 19
SC 13D/A
Innovus Pharmaceuticals, Inc.
19 Sep 19
4
Steven Boyd
18 Sep 19
3
Steven Boyd
18 Sep 19
4
HENRY JEMIL ESBER
3 Jul 19
4
VIVIAN H LIU
3 Jul 19
4
ZIAD MIRZA
3 Jul 19
4
Dean Nuhaily
3 Jul 19
4
Dean Nuhaily
2 Apr 19
4
ZIAD MIRZA
2 Apr 19
4
VIVIAN H LIU
2 Apr 19
4
HENRY JEMIL ESBER
2 Apr 19
SC 13D
Innovus Pharmaceuticals, Inc.
9 Jan 19
4
Dean Nuhaily
4 Jan 19
4
ZIAD MIRZA
4 Jan 19
4
VIVIAN H LIU
4 Jan 19
4
HENRY JEMIL ESBER
4 Jan 19
4
ZIAD MIRZA
2 Oct 18
4
Dean Nuhaily
2 Oct 18
4
VIVIAN H LIU
2 Oct 18
4
HENRY JEMIL ESBER
2 Oct 18
4
ZIAD MIRZA
19 Jul 18
4
VIVIAN H LIU
19 Jul 18
4
HENRY JEMIL ESBER
19 Jul 18
3
Ryan J Selhorn
23 Apr 18
4
Randy Berholtz
6 Apr 18
4
HENRY JEMIL ESBER
3 Apr 18
4
VIVIAN H LIU
3 Apr 18
4
ZIAD MIRZA
3 Apr 18
4
ZIAD MIRZA
27 Feb 18
4
Randy Berholtz
27 Feb 18